ZOOM First Impressions

Sponsor

DeNova Research (Other)

Overall Status

Withdrawn

CT.gov ID

NCT05739721

Collaborator

(none)

Enrollment

Location

Arms

Actual Duration (Months)

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Participants (random) will have a conversation with each other over zoom initially with their cameras off and then rate each other on attractiveness, first impressions, and self-esteem. Then both participants will turn their cameras back on and have another conversion and then again rate each other. The ratings are confidential and will not be shared with the other person.

Two months later the participants will come to the study clinic office and have an in-person conversation with someone new and rate each other.

Condition or Disease	Intervention/Treatment	Phase
Attractiveness Self Esteem First Impressions	Behavioral: Attractiveness Behavioral: Self-Esteem Behavioral: Trustworthiness	N/A

Study Design

Study Type:

Interventional

Actual Enrollment :

0 participants

Allocation:

Randomized

Intervention Model:

Crossover Assignment

Masking:

None (Open Label)

Primary Purpose:

Other

Official Title:

Effects of Video Conferencing on First Impressions and Attractiveness

Actual Study Start Date :

Nov 1, 2021

Actual Primary Completion Date :

Oct 1, 2022

Actual Study Completion Date :

Nov 1, 2022

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Zoom meeting (camera off) participants will be randomly assigned to a Zoom (San Jose, CA, USA) video conference meeting with another participant of the opposite gender	Behavioral: Attractiveness Visual attractiveness scale 0-7 Behavioral: Self-Esteem Self Esteem scale Behavioral: Trustworthiness Trustworthiness scale 0-7
Experimental: In person meeting (blindfolded) Once all subjects have been selected and enrolled in the study, participants will be randomly assigned for an in-person meeting.	Behavioral: Attractiveness Visual attractiveness scale 0-7 Behavioral: Self-Esteem Self Esteem scale Behavioral: Trustworthiness Trustworthiness scale 0-7
Experimental: Zoom meeting (camera on) participants will be randomly assigned to a Zoom (San Jose, CA, USA) video conference meeting with another participant of the opposite gender	Behavioral: Attractiveness Visual attractiveness scale 0-7 Behavioral: Self-Esteem Self Esteem scale Behavioral: Trustworthiness Trustworthiness scale 0-7
Experimental: In person meeting (no blindfold) Once all subjects have been selected and enrolled in the study, participants will be randomly assigned for an in-person meeting.	Behavioral: Attractiveness Visual attractiveness scale 0-7 Behavioral: Self-Esteem Self Esteem scale Behavioral: Trustworthiness Trustworthiness scale 0-7

Outcome Measures

Primary Outcome Measures

First Impressions [8 weeks]
The defined categories of first impressions include: Social skills, academic performance, dating success, occupational success, attractiveness, financial success, relationship success, and athletic success. The scale ranges from a score of 1 (less desirable) to 10 (most desirable). Scores closer to 10 signify a more positive outcome.
Trustworthiness scale [8 weeks]
Scale 0 (disagree) - 7 (agree). Scores closer to 7 signify a more positive outcome.
Overall Attractiveness [8 weeks]
Scale 0 (disagree) - 7 (agree). Scores closer to 7 signify a more positive outcome.

Secondary Outcome Measures

Self-Esteem [8 weeks]
The Rosenberg Self-Esteem Scale is a 10-item self-report measure of global self-esteem. It consists of 10 statements related to overall feelings of self-worth or self-acceptance. The items are answered on a four-point scale ranging from strongly agree, agree, disagree, and strongly disagree.

Eligibility Criteria

Criteria

Ages Eligible for Study:

21 Years to 39 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

Males and females of ages 21-39.
Subjects that understand the purpose and aspects of the study, freely sign the consent and complete the required treatment and follow up visit.
Subjects must all be able to speak English fluently.
Subjects must have access to video camera technology.
Fully Vaccinated against covid-19

Exclusion Criteria:

Participants younger than 21 or older than 40 will not be included.
Subjects who are pregnant or nursing.
Imprisoned populations.
Subjects who are unable to travel to the clinic.
Subjects that do not understand the purpose and aspects of the study, do not sign the consent and do not complete the required virtual session and follow-up visit will also be excluded.
Any subject that is not fully vaccinated against covid-19

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	DeNova Research	Chicago	Illinois	United States	60611

Sponsors and Collaborators

DeNova Research

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Steven H. Dayan, Doctor of Medicine, Principal Investigator, DeNova Research

ClinicalTrials.gov Identifier:

NCT05739721

Other Study ID Numbers:

ZOOM-SD-2021

First Posted:

Feb 22, 2023

Last Update Posted:

Feb 22, 2023

Last Verified:

Feb 1, 2023

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Study Results

No Results Posted as of Feb 22, 2023